Evidence map›Paper›PMID 21633802›Full record

ArticleAge (Dordrecht, Netherlands)2012

Inflammation and mortality in a frail mouse model.

Fred Ko, Qilu Yu, Qian-Li Xue, Wenliang Yao, Cory Brayton, Huanle Yang, Neal Fedarko, Jeremy Walston

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Age (Dordrecht, Netherlands), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Leveraging mitochondrial stress to improve healthy aging.Sports medicine and health science · 2026
    Review
  4. Review
  5. Review
  6. Development and validation of a prediction model for frailty in breast cancer patients with extended survival.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Physiological Systems in Promoting Frailty.Comprehensive Physiology · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Fred KoBrookdale Department of Geriatrics and Palliative Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.
Qilu Yu
Qian-Li Xue
Wenliang Yao
Cory Brayton
Huanle Yang
Neal Fedarko
Jeremy Walston
Johns Hopkins Medicine · USJohns Hopkins University · USIcahn School of Medicine at Mount Sinai · US

Funding

Technological Assessment and Solutions Core - RC4P30AG021334 · NIA · JOHNS HOPKINS UNIVERSITY · PI Jeremy D Walston · 2003 to 2026
$33.2M
Patient Oriented Research in Palliative Care and AgingK24AG022345 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI MORRISON, R. SEAN · 2003 to 2012
$1.5M
Development of a Mouse Model for FrailtyR21AG025143 · NIA · JOHNS HOPKINS UNIVERSITY · PI WALSTON, JEREMY D · 2007 to 2008
$366k
NIA NIH HHS K24 AG022345NIA NIH HHS P30 AG021334NIA NIH HHS R21 AG025143NIA NIH HHS R21-AG025143
6 · The paper itself

Abstract

Mice homozygous for targeted deletion of the interleukin 10 gene (Il-10) have been partially characterized as a model for human frailty. These mice have increased serum interleukin (IL)-6 in midlife, skeletal muscle weakness, and an altered skeletal muscle gene expression profile compared to age and sex-matched C57BL/6 (B6) control mice. In order to further characterize for use as a frailty model, we evaluated the evolution of inflammatory pathway activation, endocrine change, and mortality in these mice. Serum was collected in groups of age- and sex-matched B6.129P2-Il10(tm1Cgn)/J (IL-10(tm/tm)) mice and B6 control mice at age 12, 24, 48, 72, and 90 weeks. Cytokines including IL-6, interleukin 1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), chemokine (C-X-C motif) ligand 1 (KC), IL-12, and IL-10 were measured using electro-chemiluminescent multiplex immunoassay and insulin-like growth factor 1 (IGF-1) was measured using solid-phase enzyme-linked immunosorbent assay. A separate longitudinal cohort was monitored from age 35 weeks to approximately 100 weeks. Survival was evaluated by Kaplan-Meier survival estimates and detailed necropsy information was gathered in a subset of mice that died or were sacrificed. In IL-10(tm/tm) mice compared to B6 controls, serum IL-6, IL-1β, TNF-α, IFN-γ, KC levels were significantly elevated across the age groups, serum mean IGF-1 levels were higher in the 48-week-old groups, and overall mortality rate was significantly higher. The quadratic relationship between IGF-1 and age was significantly different between the two strains of mice. Serum IL-6 was positively associated with IGF-1 but the effect was significantly larger in IL-10(tm/tm) mice. These findings provide additional rationale for the use of the IL-10(tm/tm) mouse as a model for frailty and for low-grade inflammatory pathway activation.

Indexed as

AgingAnimalsCause of DeathCross-Sectional StudiesCytokinesDisease Models, AnimalEnzyme-Linked Immunosorbent AssayFemaleGenotypeInflammationMiceMice, Inbred C57BLCytokines

Identifiers

PMID21633802
PMCPMC3337927
OpenAlexW2000642033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.